$AMRN 2/23 gsk v teva panel rehearing 10 am et (prost, newman, moore) cafc.uscourts.gov/public-ac... 2/25 amrn 4q cc 7:30 am et 2/26 svb 9:20 am et ami fadia pt 16: "thinks eu opportunity is worth almost twice the current stock levels" 3/1 cowen 10:20 am et ken cacciatore pt 10: "shares remain undervalued any scenario, best path cease us promotional spending and sell the company" investor.amarincorp.com/eve...